[Standardizing the establishment of criteria for intraocular biological sample testing and genetic testing]

With the development of medical biotechnology, intraocular biological sample testing and genetic testing are increasingly applied in the diagnosis, treatment, and research of eye diseases. They help to quickly diagnose diseases, but also bring new problems to clinical work. This article summarizes and discusses the current situation, existing problems, and solutions of intraocular biological sample testing and genetic testing in China. It is emphasized that the clinical diagnosis is the key in ophthalmic practice, based on which criteria for intraocular biological sample testing and genetic testing need be established in a standardized manner, so as to reasonably leverage the advantages of the two tests and effectively promote the progress of ophthalmic diagnosis and treatment technology.